IP Library Granted Patent US 8,394,647
Granted Patent B2
US 8,394,647 · App. 13/029,786 · Granted Mar 12, 2013

Reducing non-covalently bound polysaccharide on supports

Inventors: Bhalchandra Lele (Newark, DE); Pratap Singh (Wilmington, DE); Asoke Chatterjee (Chadds Ford, PA)
Assignee: Siemens Healthcare Diagnostics Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,394,647
App. No.
13/029,786
Granted
Mar 12, 2013
Kind
B2
Abstract

Methods and reagents are disclosed for reducing an amount of non-covalently bound polysaccharide on a support. The method comprises contacting a support comprising both covalently bound polysaccharide and non-covalently bound polysaccharide with an aqueous solution comprising an amount of a chaotropic agent effective to remove non-covalently bound polysaccharide from the support.

Claims (25)

1. A method of reducing an amount of non-covalently bound polysaccharide on a support, the method comprising:

contacting a support comprising both covalently bound polysaccharide and non-covalently bound polysaccharide with an aqueous solution comprising an amount of a chaotropic agent effective to remove non-covalently bound polysaccharide from the support wherein the amount of chaotropic agent in the aqueous solution is about 0.1 M to about 1 M and

separating the support from the aqueous solution wherein the separating comprises contacting the aqueous solution with a membrane and wherein substantiality all of the non-covalently bound polysaccharide passes through the membrane.

2. The method according to claim 1 , wherein the polysaccharide is a dextran derivative.

3. The method according to claim 1 , wherein the support is particulate.

4. The method according to claim 1 , wherein the support is a latex support.

5. The method according to claim 1 , wherein the chaotropic agent is selected from the group consisting of trifluoroacetate salts, trichloroacetate salts, thiocyanate salts, urea salts, thiourea salts, guanidinium salts, perchlorate salts, nitrate salts, bromide salts, iodide salts, trifluoromethane sulfonate salts, hexafluorophosphate salts, and bis(trifluoromethanesulfonyl)imidourea salts.

6. The method according to claim 1 , wherein the aqueous solution comprises two or more chaotropic agents.

7. A method of preparing a conjugate of a support and an assay molecule, said method comprising:

(a) treating a support under conditions for covalently binding a polysaccharide to the support such that the support comprises both covalently bound polysaccharide and non-covalently bound polysaccharide,

(b) contacting the support with an aqueous solution comprising an amount of a chaotropic agent effective to remove non-covalently bound polysaccharide from the support wherein the amount of chaotropic agent in the aqueous solution is about 0.1 M to about 1 M,

(c) separating the support from the aqueous solution wherein the separating comprises contacting the aqueous solution with a membrane and wherein substantially all of the non-covalently bound polysaccharide passes through the membrane, and

(d) contacting the support with an assay molecule under conditions for binding of the assay molecule to the covalently bound polysaccharide.

8. The method according to claim 7 , wherein the polysaccharide is a dextran derivative.

9. The method according to claim 7 , wherein the support is particulate.

10. The method according to claim 7 , wherein the support is a latex support.

11. The method according to claim 7 , wherein the chaotropic agent is selected from the group consisting of trifluoroacetate salts, trichloroacetate salts, thiocyanate salts, urea salts, thiourea salts, guanidinium salts, perchlorate salts, nitrate salts, bromide salts, iodide salts, trifluoromethane sulfonate salts, hexafluorophosphate salts, and bis(trifluoromethanesulfonyl)imidourea salts.

12. The method according to claim 7 , wherein the aqueous solution comprises two or more chaotropic agents.

13. The method according to claim 7 , wherein the separating comprises contacting the aqueous solution to a membrane wherein substantially all of the non-covalently bound polysaccharide passes through the membrane.

14. The method according to claim 7 , wherein the assay molecule is selected from the group consisting of members of a specific binding pair and members of a signal-producing system.

15. A method of reducing an amount of non-covalently bound dextran or dextran derivative on a latex particle the method comprising:

(a) contacting a latex particle comprising both covalently bound dextran derivative and non-covalently bound dextran derivative with an aqueous solution comprising an amount of one or more chaotropic agents effective to remove non-covalently bound dextran derivative from the support, and

(b) separating the latex particle from the aqueous solution by contacting the aqueous solution with a membrane wherein substantially all of the non-covalently bound dextran derivative passes through the membrane.

16. The method according to claim 15 , wherein the chaotropic agent is selected from the group consisting of trifluoroacetate salts, trichloroacetate salts, thiocyanate salts, urea salts, thiourea salts, guanidinium salts, perchlorate salts, nitrate salts, bromide salts, iodide salts, trifluoromethane sulfonate salts, hexafluorophosphate salts, and bis(trifluoromethanesulfonyl)imidourea salts.

17. The method according to claim 15 , wherein the dextran derivative is aminodextran, dextran aldehyde, dextran sulfate or carboxydextran.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2011
From: LELE, BHALCHANDRA; SINGH, PRATAP; CHATTERJEE, ASOKE
To: SIEMENS HEALTHCARE DIAGNOSTICS INC.
Reel/Frame 026225/0318 →
Continuity (1)
Related Publication 20120214978A1 · Aug 23, 2012